CLINUVEL PHARMACUTIC-SP ADR (CLVLY:OTCMKTS)
$6.675 0.115 (1.753%)
Analysed CLINUVEL PHARMACUTIC-SP ADR (CLVLY:OTCMKTS) News Sources
CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026
15-04-2026
yahoo.com
ASX Growth Companies With High Insider Ownership For April 2026
15-04-2026
yahoo.com
High Growth Tech Stocks in Australia with Promising Potential
19-04-2026
yahoo.com
High Growth Tech Stocks In Australia To Watch
23-04-2026
yahoo.com
ASX Growth Companies With High Insider Ownership April 2026
23-04-2026
yahoo.com
CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study
24-04-2026
yahoo.com
High Growth Tech Stocks To Watch In Australia April 2026
27-04-2026
yahoo.com
ASX Growth Leaders With Insider Stakes May 2026
13-05-2026
yahoo.com
High Growth Tech Stocks In Australia May 2026
24-05-2026
yahoo.com
High Growth Tech Stocks in Australia for May 2026
26-05-2026
yahoo.com
What is the current price of CLINUVEL PHARMACUTIC-SP ADR (CLVLY:OTCMKTS)?
The current price of CLINUVEL PHARMACUTIC-SP ADR (CLVLY:OTCMKTS) is $6.675.
CLINUVEL PHARMACUTIC-SP ADR (CLVLY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of CLINUVEL PHARMACUTIC-SP ADR (CLVLY:OTCMKTS) since the previous trading day is $0.115.
CLINUVEL PHARMACUTIC-SP ADR (CLVLY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of CLINUVEL PHARMACUTIC-SP ADR (CLVLY:OTCMKTS) since the previous trading day is 1.753%.
What is the most recent average sentiment score for CLINUVEL PHARMACUTIC-SP ADR (CLVLY:OTCMKTS)?
The most recent average sentiment score for CLINUVEL PHARMACUTIC-SP ADR (CLVLY:OTCMKTS) is 65 out of 100.
What is the most recent average sentiment for CLINUVEL PHARMACUTIC-SP ADR (CLVLY:OTCMKTS)?
The most recent sentiment for CLINUVEL PHARMACUTIC-SP ADR (CLVLY:OTCMKTS) is .
SEC-8K** Filing Available For CLINUVEL PHARMACUTIC-SP ADR (CLVLY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.